Business Description
Apyx Medical Corp
NAICS : 339112
SIC : 3841
ISIN : US10211F1003
Total Employee Number:
205Description
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.7 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 3.72 | |||||
Debt-to-EBITDA | -24.69 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.05 | |||||
Beneish M-Score | -2.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.1 | |||||
3-Year EBITDA Growth Rate | 44 | |||||
3-Year EPS without NRI Growth Rate | 26.1 | |||||
3-Year FCF Growth Rate | 28.9 | |||||
3-Year Book Growth Rate | -31.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.87 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.4 | |||||
9-Day RSI | 21.23 | |||||
14-Day RSI | 27.88 | |||||
3-1 Month Momentum % | 14.29 | |||||
6-1 Month Momentum % | 16.46 | |||||
12-1 Month Momentum % | 89.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.68 | |||||
Quick Ratio | 4.53 | |||||
Cash Ratio | 2.95 | |||||
Days Inventory | 158.24 | |||||
Days Sales Outstanding | 84.21 | |||||
Days Payable | 47.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.5 | |||||
Shareholder Yield % | -0.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.5 | |||||
Operating Margin % | -6.06 | |||||
Net Margin % | -14.78 | |||||
EBITDA Margin % | -2.75 | |||||
FCF Margin % | -18.9 | |||||
OCF Margin % | -17.33 | |||||
ROE % | -84.42 | |||||
ROA % | -14.09 | |||||
ROIC % | -14.95 | |||||
3-Year ROIIC % | -370.56 | |||||
ROC (Joel Greenblatt) % | -11.62 | |||||
ROCE % | -4.69 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.21 | |||||
PB Ratio | 11.98 | |||||
Price-to-Tangible-Book | 12.19 | |||||
EV-to-EBIT | -58.66 | |||||
EV-to-EBITDA | -87.27 | |||||
EV-to-Revenue | 2.4 | |||||
EV-to-Forward-Revenue | 2.35 | |||||
EV-to-FCF | -12.68 | |||||
Price-to-GF-Value | 1.37 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 42.67 | |||||
Earnings Yield (Greenblatt) % | -1.7 | |||||
FCF Yield % | -8.66 | |||||
Forward Rate of Return (Yacktman) % | 12.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apyx Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 50.192 | ||
| EPS (TTM) (€) | -0.173 | ||
| Beta | 0.662 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.43 | ||
| Volatility % | 64.44 | ||
| 14-Day RSI | 27.88 | ||
| 14-Day ATR (€) | 0.129817 | ||
| 20-Day SMA (€) | 3.299 | ||
| 12-1 Month Momentum % | 89.69 | ||
| 52-Week Range (€) | 1.57 - 4.14 | ||
| Shares Outstanding (Mil) | 42.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apyx Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apyx Medical Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 81 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 80 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-11 14:30 | 3.44 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | 3.66 (+0.00%) | ||
| General meeting for 2026 | 2026-08-06 09:00 | 3.66 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 3.66 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:00 | 2.48 (+6.90%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 2.48 (+6.90%) | ||
| The Citizens Life Sciences Conference | 2026-03-11 08:25 | 2.88 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-10 08:00 | 2.60 (+0.00%) |
Show
Entries
Apyx Medical Corp Frequently Asked Questions
What is Apyx Medical Corp(FRA:BOV)'s stock price today?
The current price of FRA:BOV is €2.56. The 52 week high of FRA:BOV is €4.14 and 52 week low is €1.57.
When is next earnings date of Apyx Medical Corp(FRA:BOV)?
The next earnings date of Apyx Medical Corp(FRA:BOV) is 2026-11-06 Est..
Does Apyx Medical Corp(FRA:BOV) pay dividends? If so, how much?
Apyx Medical Corp(FRA:BOV) does not pay dividend.
Press Release
Articles on Apyx Medical Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers